Ocuphire Pharma Pre-Tax Profit Margin 2010-2024 | IRD
Ocuphire Pharma pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Ocuphire Pharma Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2024-06-30 |
$0.02B |
$-0.01B |
-82.35% |
| 2024-03-31 |
$0.02B |
$-0.01B |
-55.00% |
| 2023-12-31 |
$0.02B |
$-0.01B |
-50.00% |
| 2010-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2010-03-31 |
$0.00B |
$-0.01B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.000B |
$0.000B |
|
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|
